Posted in

Biostatistics Director

Biostatistics Director

CompanyExelixis
LocationKing of Prussia, PA, USA, Alameda, CA, USA
Salary$187500 – $266000
TypeFull-Time
DegreesBachelor’s, Master’s, PhD
Experience LevelSenior, Expert or higher

Requirements

  • BS/BA degree in Statistics/Biostatistics or related discipline and a minimum of thirteen years of related experience; or,
  • MS/MA degree in Statistics/Biostatistics or related discipline and a minimum of eleven years of related experience; or,
  • PhD in Statistics/Biostatistics or related discipline and a minimum of eight years of related experience; or,
  • Equivalent combination of education and experience.
  • May require certification in assigned area.

Responsibilities

  • Work with department head to develop and implement department standards and practices.
  • Direct the statistical design, conduct, and analysis of clinical trials in all phases.
  • Review protocols and case report forms for soundness of trial design.
  • Review and or author statistical analysis plans for all phases of a trial.
  • Perform analysis, interpret study results, and collaborate with clinical team to produce interim reports, final reports, and publications.
  • Direct the development, validation and summary of integrated safety and efficacy summaries.
  • Interact with FDA or EU Authority staff to ensure clinical studies meet regulatory requirements.
  • Attend meetings with FDA or EU Authority to ensure ongoing agreement on project development.
  • Contribute to the development of Requests-for-Proposals.
  • Evaluate and manage contract research organizations and other vendors, including scope-of-work, timelines, deliverables and budgets.
  • Responsible for all statistical oversight within a therapeutic area.

Preferred Qualifications

  • Managed and or supported clinical trials, preferably in the therapeutic area of oncology and in the biotech/pharmaceutical industry.
  • Preferably led a phase III clinical trial.
  • In-depth knowledge of CDISC standards.
  • Management and statistical analysis of data obtained from Phase I – IV clinical studies in support of US NDAs.
  • Direct experience with FDA/EU Authority preferred.